<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Bauvin B</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The complexity of COVID-19 requires approaches that extend beyond symptom-based descriptors. Multi-omic data, combining clinical, proteomic, and metabolomic information, offer a more detailed view of disease mechanisms and biomarker discovery.&lt;h4>Methods&lt;/h4>As part of a large-scale Quebec initiative, we collected extensive datasets from COVID-19 positive and negative patient samples. Using a multi-view machine learning framework with ensemble methods, we integrated thousands of features across clinical, proteomic, and metabolomic domains to classify COVID-19 status. We further applied a novel feature relevance methodology to identify condensed signatures.&lt;h4>Results&lt;/h4>Our models achieved a balanced accuracy of 89% ± 5% despite the high-dimensional nature of the data</pubmed_abstract><journal>Frontiers in bioinformatics</journal><pagination>1645785</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12497780</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Extracting a COVID-19 signature from a multi-omic dataset.</pubmed_title><pmcid>PMC12497780</pmcid><pubmed_authors>Quach C</pubmed_authors><pubmed_authors>Carpentier C</pubmed_authors><pubmed_authors>Huusaari R</pubmed_authors><pubmed_authors>Bauvin B</pubmed_authors><pubmed_authors>Godon T</pubmed_authors><pubmed_authors>Rousu J</pubmed_authors><pubmed_authors>Corbeil J</pubmed_authors><pubmed_authors>Deraspe M</pubmed_authors><pubmed_authors>Bachelot G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extracting a COVID-19 signature from a multi-omic dataset.</name><description>&lt;h4>Introduction&lt;/h4>The complexity of COVID-19 requires approaches that extend beyond symptom-based descriptors. Multi-omic data, combining clinical, proteomic, and metabolomic information, offer a more detailed view of disease mechanisms and biomarker discovery.&lt;h4>Methods&lt;/h4>As part of a large-scale Quebec initiative, we collected extensive datasets from COVID-19 positive and negative patient samples. Using a multi-view machine learning framework with ensemble methods, we integrated thousands of features across clinical, proteomic, and metabolomic domains to classify COVID-19 status. We further applied a novel feature relevance methodology to identify condensed signatures.&lt;h4>Results&lt;/h4>Our models achieved a balanced accuracy of 89% ± 5% despite the high-dimensional nature of the data</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-04T06:56:33.59Z</modification><creation>2026-05-06T03:11:55.08Z</creation></dates><accession>S-EPMC12497780</accession><cross_references><pubmed>41059484</pubmed><doi>10.3389/fbinf.2025.1645785</doi></cross_references></HashMap>